Form 8-K - Current report:
SEC Accession No. 0001193125-24-002542
Filing Date
2024-01-04
Accepted
2024-01-04 17:12:33
Documents
12
Period of Report
2024-01-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d687857d8k.htm   iXBRL 8-K 24165
  Complete submission text file 0001193125-24-002542.txt   145566

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dyn-20240104.xsd EX-101.SCH 2846
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyn-20240104_lab.xml EX-101.LAB 17977
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyn-20240104_pre.xml EX-101.PRE 11256
6 EXTRACTED XBRL INSTANCE DOCUMENT d687857d8k_htm.xml XML 3341
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39509 | Film No.: 24513206
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)